Nov 14, 2022
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.79 to $0.02.
The split itself did not change the total investment value.
Kintara Therapeutics, Inc. (KTRA) trades on the NASDAQ Capital Market in the Biotechnology industry.
Kintara Therapeutics, Inc. company overviewThe latest split shown was on November 14, 2022. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
This history records 3 reverse splits between May 20, 2016 and November 14, 2022.